Dr. Philip A. Gideon, MD

Dr. Gideon practices at Banner Alzheimer's Institute in Sun City, Arizona.

Dr. Gideon's NPI, 1316981467, was assigned on June 16, 2006. Dr. Gideon holds Arizona license 35544.

Dr. Gideon's primary practice is Banner Alzheimer's Institute, at 10515 W Santa Fe Dr, Sun City, AZ 85351 in Maricopa County. The practice phone is (602) 747-4000.

Dr. Gideon's primary practice is Banner Alzheimer's Institute in Sun City, Arizona. Dr. Gideon is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner - University Medical Group. Dmand AI also links Dr. Gideon to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gideon practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gideon's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gideon is licensed in Arizona.

CMS data shows 1,327 Medicare services from Dr. Gideon across 20 procedure codes in 2024, for 600 Medicare patients. Medicare paid $58,567 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 600 Medicare patients who saw Dr. Gideon in 2024. The largest group is 65 to 74, with 256 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gideon's median patient age at 66, with 45% women.

In 2024, Dr. Gideon wrote 446 Medicare Part D claims for 92 patients. 80% of them were for generic drugs. CMS names the drug for 366 of them, across 15 drugs with 11 or more claims each, at $73,676 in total drug cost. In 2023, CMS named 719 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Gideon for performance year 2024, reported as part of a group. Dr. Gideon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gideon as offering telehealth.

Dmand AI links 4 papers to Dr. Gideon in 2023. 2023 was the busiest year, with 3. Dr. Gideon's most frequent co-authors are Himanshu Md Agarwal, MD, Joseph R. Aragon, MD and Joseph R. Aragon, MD.

Dmand AI links Dr. Gideon to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Mitral Valve Insufficiency and Heart Valve Diseases.

CMS Open Payments shows 138 general payments to Dr. Gideon from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Abbott Laboratories paid the most, $3,726.